Spending on HIV: no pattern between epidemic types

January 2010
PharmacoEconomics & Outcomes News;1/9/2010, Issue 594, p9
The article discusses a study of the spending on HIV treatment in low-income and middle-income countries. Results showed that a total of 2.6 billion U.S. dollars was spent on HIV programmes by the countries involved in the study. The highest spending per capital was posted by Botswana, which stood at 70.4 U.S. dollars. The average per-capita spending of the remaining sub-Saharan African countries was 5.9 U.S. dollars.


Related Articles

  • (HIV/AIDS) States Can Vie for $20M in Ryan White Part B Funding.  // Community Health Funding Week;1/1/2010, p10 

    The article offers information on Ryan White Part B HIV Care Grant Program. It is stated that 20 million dollars have been allocated for the program. Part B funding is used to assist states in developing or enhancing access to a comprehensive continuum of high quality, community-based care for...

  • Health Care Financing in Nigeria: Prospects and Challenges. Obansa, S. A. J.; Orimisan, Akinnagbe // Mediterranean Journal of Social Sciences;Jan2013, Vol. 4 Issue 1, p221 

    No abstract available.

  • Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries? Dongbao Yu; Souteyrand, Yves; Banda, Mazuwa A.; Kaufman, Joan; Perriëns, Joseph H. // Globalization & Health;2008, Vol. 4, Special section p1 

    Background: There is increasing debate about whether the scaled-up investment in HIV/AIDS programs is strengthening or weakening the fragile health systems of many developing countries. This article examines and assesses the evidence and proposes ways forward. Discussion: Considerably increased...

  • Slow down the CARE process. Monette-Shaw, Patrick // Bay Area Reporter;9/19/2002, Vol. 32 Issue 38, p6 

    Discusses the funding problems encountered by the HIV Health Services Council (CARE Council) in San Francisco, California. Implementation of reduction process to all CARE-funded AIDS service organization; Reduction of allocations to two programs.

  • Comparing State-Only Expenditures for AIDS. Rowe, Mona J.; Ryan, Caitlin C. // American Journal of Public Health;Apr88, Vol. 78 Issue 4, p424 

    The State AIDS Policy Center at the Inter-governmental Health Policy Project (IHPP) at George Washington University surveyed all 50 states to determine state AIDS (acquired immunodeficiency syndrome) expenditures, without Medicaid or federal funds, for fiscal 1984–88. During this period,...

  • GSK announces new commitments to fight HIV/AIDS.  // PharmacoEconomics & Outcomes News;7/25/2009, Issue 583, p10 

    The article outlines the measures announced by GlaxoSmithKline to fight HIV/AIDS in sub-Saharan Africa. The company intends to invest up to 50 million British pounds over 10 years to form the Positive Action Children Fund. The fund will support those working with pregnant mothers to prevent...

  • Improving access to treatment for HIV in sub-Saharan Africa. Bautista-Arredondo, Sergio; Wirtz, Veronika J.; Bertozzi, Stefano M. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/4/2010, Vol. 341 Issue 7784, p1173 

    The authors stress the need to improve treatment access for human immunodeficiency virus (HIV) in sub-Saharan Africa and the importance of additional funding. They also note the importance of using the funding more efficiently. They reveal that the funding for HIV and acquired immune deficiency...

  • OAC prepares for HIV needs assessment. Bone, Travis D. // Gay & Lesbian Times;1/22/2004, Issue 839, p14 

    Reports on the Office of AIDS Coordination's countrywide HIV needs assessment to evaluate services and spending in HIV/AIDS healthcare in the U.S. Efforts of OAC to address the changing issues in HIV/AIDS healthcare; Awarding of grants to eligible metropolitan areas based on case rates.

  • Poland's Health-Care System Ailing. Kosc, Wojciech // Transitions Online;1/19/2004, pN.PAG 

    Reports on the impact of the decision of the National Health Fund (NFZ) in Poland not to allocate funds for HIV treatment in the 2004 budget on the prevalence of HIV cases in the country. Setbacks of the 2002 law creating the central health fund; Function of NFZ; Verdict of the tribunal on the NFZ.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics